- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
InspireMD Inc (NSPR)
InspireMD Inc stock price live, this page displays NASDAQ NSPR stock exchange data. View the NSPR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the InspireMD Inc real time stock price chart below.
What Is the InspireMD Inc Stock Price Today?
The InspireMD Inc stock price today is 0.692.
What Is the Stock Symbol for InspireMD Inc?
The stock symbol for InspireMD Inc is "NSPR."
What Stock Exchange Does InspireMD Inc Trade On?
InspireMD Inc is listed and trades on the NASDAQ stock exchange.
Is InspireMD Inc a Good Stock to Buy?
Determining whether InspireMD Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NSPR quote. (ISIN: US45779A8466)
What Is the InspireMD Inc Stock Price Today?
The InspireMD Inc stock price today is 0.692.
What Is the Stock Symbol for InspireMD Inc?
The stock symbol for InspireMD Inc is "NSPR."
What Stock Exchange Does InspireMD Inc Trade On?
InspireMD Inc is listed and trades on the NASDAQ stock exchange.
Is InspireMD Inc a Good Stock to Buy?
Determining whether InspireMD Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NSPR quote. (ISIN: US45779A8466)
NASDAQ
Currency in USD
0.692
-0.007(-0.96%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.660
0.711
52 wk Range
0.630
2.932
NSPR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6600.711
52 wk Range
0.6302.932
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NSPR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
3.667
Upside
+429.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- InspireMD director Paul Stuka buys $88,026 in shares
- Investing.com
- Top insider buys and sells disclosed on Friday
- Investing.com
- InspireMD director Paul Stuka buys $17,500 in shares
- Investing.com
- InspireMD director Paul Stuka buys $17,500 in shares
- Investing.com
- InspireMD CCO Shane Gleason sells $189,594 in stock
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.667
(+429.87% Upside)
InspireMD Inc Earnings Call Summary for Q1/2026
- InspireMD Q1 2026 revenue surged 122% YoY to $3.4M, beating forecast of $2.38M; EPS of -$0.16 exceeded -$0.20 estimate.
- Stock fell 8.52% in premarket to $1.052 despite earnings beat, reflecting concerns over temporary U.S. operations pause for CGuard Prime.
- Operating expenses climbed 24.6% YoY to $14.7M; net loss totaled $13.7M with gross profit margin at 20.2%.
- Company withdrew full-year 2026 revenue guidance due to U.S. operational pause; international sales expected to sustain revenue.
- CEO expects U.S. operations to resume pending FDA approval; analysts maintain $4-$6 price targets despite 46% six-month stock decline.
Last Updated: 2026-05-04, 05:10 p/m
Read Full TranscriptEarnings
Latest Release
May 04, 2026
EPS / Forecast
-0.16 / -0.20
Revenue / Forecast
3.4M / 2.38M
Compare NSPR to Peers and Sector
Metrics to compare | NSPR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNSPRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −2.8x | −0.4x | |
PEG Ratio | −0.06 | −0.14 | 0.00 | |
Price/Book | 0.7x | 3.8x | 2.6x | |
Price / LTM Sales | 3.0x | 2.5x | 3.0x | |
Upside (Analyst Target) | - | 62.0% | 49.1% | |
Fair Value Upside | Unlock | 15.6% | 6.3% | Unlock |
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the InspireMD (NSPR) Stock Price Today?
The InspireMD stock price today is 0.692 USD.
What Stock Exchange Does InspireMD Trade On?
InspireMD is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for InspireMD?
The stock symbol for InspireMD is "NSPR."
What Is the InspireMD Market Cap?
As of today, InspireMD market cap is 32.410M USD.
What Is InspireMD's Earnings Per Share (TTM)?
The InspireMD EPS (TTM) is -0.705.
When Is the Next InspireMD Earnings Date?
InspireMD will release its next earnings report on Aug 11, 2026.
From a Technical Analysis Perspective, Is NSPR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has InspireMD Stock Split?
InspireMD has split 6 times.
How Many Employees Does InspireMD Have?
InspireMD has 127 employees.
What is the current trading status of InspireMD (NSPR)?
As of Jul 06, 2026, InspireMD (NSPR) is trading at a price of 0.692 USD, with a previous close of 0.699 USD. The stock has fluctuated within a day range of 0.660 USD to 0.711 USD, while its 52-week range spans from 0.630 USD to 2.932 USD.
What Is InspireMD (NSPR) Price Target According to Analysts?
The average 12-month price target for InspireMD is 3.667 USD, with a high estimate of 4 USD and a low estimate of 3 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +429.87% Upside potential.
What Is the NSPR Premarket Price?
NSPR's last pre-market stock price is 0.654 USD. The pre-market share volume is 2.000, and the stock has decreased by -0.045, or -6.380%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.